• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[A case of limited form of Wegener's granulomatosis associated with persistent high titer of serum antineutrophil cytoplasmic antibodies].

作者信息

Akamatsu A, Yamauchi M, Ikeda Y, Yoshida M

机构信息

Ehime Central Prefectural Hospital, Division of Internal Medicine, Matsuyama-city.

出版信息

Ryumachi. 1992 Feb;32(1):52-7.

PMID:1604417
Abstract

A thirty-six year-old male was admitted to our hospital because of a two year history of orbital mass. He had experienced inflammatory tumor of right lung six years before admission. Both the lung tumor and orbital mass were revealed as chronic panarteritis with diffuse necrotizing lesions. He was treated with low dose prednisolone, but the orbital mass gradually enlarged. We detected fluorescent cytoplasmic pattern of antineutrophil cytoplasma antibodies (ANCA) by the indirect immunofluorescence method (IF). We ascertained this case to be a limited form of Wegener's granulomatosis (WG) by histopathological finding and positive ANCA. The value of ANCA, estimated by enzyme linked immunosorbent assay (ELISA) was rather higher than that of generalized form of WG in other reports. There was no reduction of the size of orbital mass and the value of ANCA despite strong immunosuppressive therapy. In this case, the value of ANCA didn't represented disease activity. The presence of histopathological findings such as those observed in the present patient, i.e., abnormally high ANCA levels not associated with disease severity or progression, which are not in accordance with those conventionally reported, was considered very interesting in terms of the prevailing beliefs concerning involvement of ANCA in the mechanism of onset of WG.

摘要

相似文献

1
[A case of limited form of Wegener's granulomatosis associated with persistent high titer of serum antineutrophil cytoplasmic antibodies].
Ryumachi. 1992 Feb;32(1):52-7.
2
The utility of detecting of autoantibodies against neutrophil cytoplasmic components in Wegener's granulomatosis.检测抗中性粒细胞胞浆成分自身抗体在韦格纳肉芽肿病中的作用。
Ann Allergy. 1989 Nov;63(5):411-6.
3
[Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment].[抗中性粒细胞胞浆抗体检测在韦格纳肉芽肿病诊断及病情活动度判断中的价值]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1997 Aug;19(4):284-7.
4
Antineutrophil cytoplasmic antibodies: clinical characteristics of 10 patients with the perinuclear pattern of immunofluorescence on ANCA testing.抗中性粒细胞胞浆抗体:10例抗中性粒细胞胞浆抗体检测呈核周型免疫荧光模式患者的临床特征
South Med J. 1992 Feb;85(2):132-8.
5
[Clinical significance of anti-neutrophil cytoplasmic antibody and pathogenetic role of adhesion molecules for Wegener's granulomatosis].[抗中性粒细胞胞浆抗体的临床意义及黏附分子在韦格纳肉芽肿发病机制中的作用]
Hokkaido Igaku Zasshi. 1996 Jul;71(4):517-29.
6
[A child with Wegener's granulomatosis].[一名患有韦格纳肉芽肿病的儿童]
Tijdschr Kindergeneeskd. 1992 Apr;60(2):52-6.
7
Diagnostic specificity of anti-neutrophil cytoplasmic antibodies (ANCA) in otorhinolaryngological diseases.
Acta Otolaryngol Suppl. 1994;511:204-7.
8
Detection and clinical implication of anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis and rapidly progressive glomerulonephritis.韦格纳肉芽肿病和急进性肾小球肾炎中抗中性粒细胞胞浆抗体的检测及其临床意义
Clin Nephrol. 1989 Oct;32(4):159-67.
9
[Anti-neutrophil cytoplasmic anti body (ANCA)-negative limited form of Wegener's granulomatosis; report of a case].[抗中性粒细胞胞浆抗体(ANCA)阴性的局限性韦格纳肉芽肿病;一例报告]
Kyobu Geka. 2007 Jul;60(7):591-4.
10
Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.通过检测抗中性粒细胞胞浆抗体水平预测韦格纳肉芽肿的复发:一项前瞻性研究。
Arthritis Rheum. 2000 Sep;43(9):2025-33. doi: 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O.